{"id":12632,"date":"2024-12-11T11:57:18","date_gmt":"2024-12-11T16:57:18","guid":{"rendered":"https:\/\/www.bu.edu\/innovate\/?post_type=profile&#038;p=12632"},"modified":"2026-01-29T09:19:33","modified_gmt":"2026-01-29T14:19:33","slug":"malena-therapeutics","status":"publish","type":"profile","link":"https:\/\/www.bu.edu\/innovate\/profile\/malena-therapeutics\/","title":{"rendered":"Malena Therapeutics"},"content":{"rendered":"<p>Malena Therapeutics is developing molecules to target and degrade RNA-binding proteins associated with neurodegeneration, aiming to address the multifactorial causes of conditions like Alzheimer&#8217;s disease.<\/p>\n","protected":false},"author":20921,"template":"","tags":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/innovate\/wp-json\/wp\/v2\/profile\/12632"}],"collection":[{"href":"https:\/\/www.bu.edu\/innovate\/wp-json\/wp\/v2\/profile"}],"about":[{"href":"https:\/\/www.bu.edu\/innovate\/wp-json\/wp\/v2\/types\/profile"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/innovate\/wp-json\/wp\/v2\/users\/20921"}],"version-history":[{"count":1,"href":"https:\/\/www.bu.edu\/innovate\/wp-json\/wp\/v2\/profile\/12632\/revisions"}],"predecessor-version":[{"id":12637,"href":"https:\/\/www.bu.edu\/innovate\/wp-json\/wp\/v2\/profile\/12632\/revisions\/12637"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/innovate\/wp-json\/wp\/v2\/media?parent=12632"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bu.edu\/innovate\/wp-json\/wp\/v2\/tags?post=12632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}